A new drug has been developed that
effectively treats three recently discovered rare
autoinflammatory diseases, a group of illnesses causing
recurring episodes of swelling and fever, according to a study
published in the The New England Journal of Medicine.
The effectiveness of the drug, which uses a specific
antibody, was assessed by worldwide clinical testing coordinated
by Rome's Bambino Gesù pediatric hospital.
ALL RIGHTS RESERVED © Copyright ANSA